Ark makes breakthrough in targeted gene therapy delivery
Avoids harmful consequences of therapeutic gene being inserted in wrong place
09-Aug-2005 -
Ark Therapeutics Group plc announceds that its scientists in Finland have discovered a novel gene therapy delivery technology which selectively inserts DNA into the specific therapeutic site in the genome (targeted integration). This technology is the subject of an Ark PCT filing.
The existing ...
chromosomes
clinical trials
Finland
+5